Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Neuronetics Inc
(NQ:
STIM
)
2.520
+0.090 (+3.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Neuronetics Inc
< Previous
1
2
3
4
Next >
Short Volatility Alert: Neuronetics, Inc.
October 21, 2022
On Thursday, shares of Neuronetics, Inc. (NASDAQ: STIM) experienced volatile short activity. After the activity, the stock price went down -1.74% to $2.83. The overall sentiment for STIM has been...
Via
Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...
Via
Benzinga
Short Volatility Alert: Neuronetics, Inc.
September 23, 2022
On Thursday, shares of Neuronetics, Inc. (NASDAQ: STIM) experienced volatile short activity. After the activity, the stock price went up +0.76% to $2.65. The overall sentiment for STIM has been...
Via
Benzinga
Despite Competition This Analyst Finds BrainsWay Attractive
August 11, 2022
Via
Benzinga
Recap: Neuronetics Q2 Earnings
August 02, 2022
Neuronetics (NASDAQ:STIM) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
September 28, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 27, 2022
Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.
Via
Benzinga
Read Why Neuronetics Shares Are Trading Higher Today
July 19, 2022
Via
Benzinga
Recap: Neuronetics Q1 Earnings
May 12, 2022
Neuronetics (NASDAQ:STIM) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 19, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 09, 2022
Via
Benzinga
Neuronetics's Earnings: A Preview
August 01, 2022
Neuronetics (NASDAQ:STIM) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Neuronetics will...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 20, 2022
Via
Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
July 20, 2022
Investors ready to start trading early this morning will want to check out the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
July 19, 2022
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...
Via
Benzinga
NCR Stock Pops 13% on Buyout News
July 19, 2022
NCR (NCR) stock is rising higher on Tuesday following reports that private-equity firm Veritas wants to buy the company and take it private.
Via
InvestorPlace
Why Is Neuronetics (STIM) Stock Up 12% Today?
July 19, 2022
Neuronetics (STIM) stock is taking off on Tuesday after the announcing approval from the FDA for a new use of a metal health treatment.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 19, 2022
Via
Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
May 11, 2022
Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247...
Via
Benzinga
Earnings Scheduled For May 12, 2022
May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
Via
Benzinga
99 Biggest Movers From Yesterday
May 12, 2022
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 10, 2022
Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million.
Via
Benzinga
Neuronetics Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 29, 2022
Neuronetics (NASDAQ:STIM) will host a conference call at 08:30 AM ET on May 12, 2022, to discuss Q1 2022 earnings results. How to Attend Neuronetics (STIM) Conference Call Follow this link to access...
Via
Benzinga
Executives Buy Around $1M Of 4 Penny Stocks
April 05, 2022
The ISM services PMI rose to 58.3 in March from 56.5 in the previous month. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Insiders Buying These 4 Penny Stocks
March 30, 2022
The Nasdaq Composite gained around 60 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Neuronetics's Return On Capital Employed Insights
March 10, 2022
According to data from Benzinga Pro, during Q4, Neuronetics's (NASDAQ:STIM) reported sales totaled $15.02 million. Despite a 6.32% increase in earnings, the company posted a loss...
Via
Benzinga
Neuronetics Posts Better Than Expected Q4 Results Despite Lower NeuroStar Therapy System Sales
March 08, 2022
Neuronetics Inc (NASDAQ: STIM) reported Q4 FY21 sales of $15.02 million, down 4% Y/Y, exceeding previously issued guidance of $13.0 million - $14.0 million and the...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.